In the NOPHO ALL2008 protocol , patients are randomized to 8 or 15 doses of intramuscular PEG-asparaginase ( Oncaspar ) 1,000 IU/m ( 2 ) / dose administered at 2 or 6 weeks intervals during a total period of 30 weeks .